Skip to content

13D/A filed by GOLDENTREE ASSET MANAGEMENT LP

GOLDENTREE ASSET MANAGEMENT LP and 3 other reporting persons reported 8,875,543 shares of Keenova Therapeutics plc, 22.4% of the class, as of 2026-11-06, in a 13D/A accepted by EDGAR 2026-11-10 21:57:39 UTC.

Accession
0001493152-26-051012
Filed
2026-11-10
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Subject
Keenova Therapeutics plc
Shares
8,875,543
Percent of class
22.4%
Event date
2026-11-06

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group GOLDENTREE ASSET MANAGEMENT LP.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
GoldenTree Asset Management LPPN08,821,92808,821,9288,821,92822.3%
GoldenTree Asset Management LLCOO08,821,92808,821,9288,821,92822.3%
Steven A. TananbaumIN53,6158,821,92853,6158,821,9288,875,54322.4%
GoldenTree Master Fund, Ltd.CO02,510,13902,510,1392,510,1396.3%

Amendment chain

FilingRoleFiledAcceptedIngested
13D/A 0001493152-26-045957 amendment2026-10-06
13D/A 0001493152-26-051012this filing2026-11-10